Table 1 Baseline characteristics of the included studies
Author and year | Study design | Group | Female | Mean follow-up(months) | Sample size | Mean age (years) | Cup fixation | Posterior approach | Hardinge approach |
|---|---|---|---|---|---|---|---|---|---|
Achudan, 2022 | Retrospective Cohort | DM | 91 | 24,1 | 42 | 68 | Uncemented | 129 | 0 |
THA | 42,7 | 87 | 70,9 | ||||||
Agarwala, 2021 | Prospective Cohort | DM | 53 | 12 | 52 | 75,5 | Mixed cases (uncemented/ cemented) | 0 | 103 |
THA | 51 | 73,3 | |||||||
Cnudde, 2022 | Retrospective Cohort | DM | 102 | 12 | 172 | 77,9 | MD | 103 | 69 |
THA | 379 | 605 | 72,3 | 262 | 372 | ||||
Alberio, 2021 | Retrospective Cohort | DM | 42 | 23 | 24 | 77 | Uncemented | 48 | 0 |
THA | 24 | 78,3 | |||||||
Griffin, 2016 | RCT | DM | MD | 12 | 9 | N/A | Uncemented | MD | MD |
THA | 10 | ||||||||
Hoggett, 2023 | Retrospective Cohort | DM | MD | 41 | 106 | 76 | Cemented | 102 | 4 |
THA | 42 | 189 | 73 | 140 | 49 | ||||
Hoskins, 2021 | Retrospective Cohort | DM | 1265 | 24 | 1778 | 75 | MD | MD | MD |
THA | 7123 | 40 | 8582 | 73 | |||||
Parhamfar, 2023 | RCT | DM | 42 | 18 | 40 | 63 | MD | 0 | 84 |
THA | 44 | 64 | |||||||
Rashed, 2020 | RCT | DM | 32 | 12 | 31 | 66,3 | Cemented | 62 | 0 |
THA | 31 | 68 | |||||||
Rashed, 2020 | Retrospective Cohort | DM | 240 | 12 | 223 | 72,3 | MD | 334 | 0 |
THA | 111 | 72,1 | |||||||
Rogmark, 2022 | Retrospective Cohort | DM | 1374 | 60 | 2242 | 76 | Mixed cases (uncemented/ cemented) | 1114 | 4234 1128 |
THA | 4120 | 6726 | 75,2 | 2492 | |||||
Sadozai, 2021 | Retrospective Cohort | DM | MD | 37 | 127 | N/A | Mixed cases (uncemented/ cemented) | MD | MD |
THA | 195 | ||||||||
Tarasevicius, 2013 | Prospective Cohort | DM | 61 | 12 | 41 | 75 | Cemented | 84 | 0 |
THA | 43 | 76 |